Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Journal of Neuroscience

Jan 25, 2017 12:05 pm UTC| Business

Single Administration of AAV-Vectored Anti-Tau Monoclonal Antibody Markedly Reduced Tau Pathology in Preclinical Model Voyager Optimizing the Delivery of Anti-Tau Monoclonal Antibodies with its Proprietary VY-TAU01...

McDermott awarded offshore pipelay contract in the Middle East

Jan 25, 2017 12:02 pm UTC| Business

Back-to-back awards with Middle East customers demonstrates McDermott’s experience and proven performanceContract builds off McDermott’s successful track record in the Middle East Sizeable award will be included in Q4 2016...

Malvern Bancorp, Inc. Reports First Fiscal Quarter Earnings; Momentum Carries Malvern to net profit of $1.2 million, or $0.18 per Share

Jan 25, 2017 12:00 pm UTC| Business

Earnings Driven by Loan Growth and Higher Net Interest Income PAOLI, Pa., Jan. 25, 2017 -- Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company"), parent company of Malvern Federal Savings Bank (“Malvern” or the “Bank”),...

uniQure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs

Jan 25, 2017 12:00 pm UTC| Business

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Jan. 25, 2017 -- uniQure N.V.(Nasdaq:QURE), a leader in human gene therapy, today announced the appointment of Alexander Kuta, Ph.D., as Senior Vice President of...

IRADIMED CORPORATION to Hold 2016 Fourth Quarter Financial Results Conference Call on February 6th

Jan 25, 2017 12:00 pm UTC| Business

WINTER SPRINGS, Fla., Jan. 25, 2017 -- IRADIMED CORPORATION(NASDAQ:IRMD) announced today that the Company will release its 2016 fourth quarter financial results before the market opens on Monday, February 6th. IRADIMED...

pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information

Jan 25, 2017 12:00 pm UTC| Business

WATERTOWN, Mass., Jan. 25, 2017 -- pSivida Corp.(NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye diseases, today announced its financial results...

Universal Stainless Reports Fourth Quarter 2016 Results

Jan 25, 2017 12:00 pm UTC| Business

Fourth Quarter Net Sales Total $34.2 Million, up 7.8% Versus the Fourth Quarter of 2015Fourth Quarter Net Loss Totals $0.22 per Diluted Share, Improved from a Net Loss per Diluted Share of $0.48 in the Fourth Quarter of...